Patents by Inventor Vivekanand P. Kamath

Vivekanand P. Kamath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10905683
    Abstract: Use of a compound of formula (I): wherein A, X, Y, R1 and R2 as defined herein, in treating hereditary angioedema is disclosed. A composition containing the compounds, a polar organic solvent or a mixture thereof; and optionally a co-solvent, is also disclosed.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: February 2, 2021
    Assignee: BioCryst Pharmaceuticals, Inc.
    Inventors: Yarlagadda S Babu, Vivekanand P Kamath, Walter Gowan
  • Publication number: 20170266172
    Abstract: Use of a compound of formula (I): wherein A, X, Y, R1 and R2 as defined herein, in treating hereditary angioedema is disclosed. A composition containing the compounds, a polar organic solvent or a mixture thereof; and optionally a co-solvent, is also disclosed.
    Type: Application
    Filed: August 24, 2015
    Publication date: September 21, 2017
    Inventors: Yarlagadda S BABU, Vivekanand P KAMATH, Walter GOWAN
  • Publication number: 20090012104
    Abstract: Described are compounds of the general formula (I), VI and (VII). Also described are pharmaceutical compositions comprising the compounds identified. The compounds and pharmaceutical compositions described are inhibitors of 5?-methylthioadenosine/S-adenosylhomocystein nucleosidase (MTAN) and/or 5?-methylthioadenosine phosphorylase (MTAP). Methods of treatment using the compounds and pharmaceutical compositions described are also provided for preventing and/or treating disease states and/or conditions by inhibiting MTAN and/or MTAP in patients.
    Type: Application
    Filed: July 26, 2005
    Publication date: January 8, 2009
    Inventors: Yarlagadda S. Babu, Vivekanand P. Kamath, Philip E. Morris, JR.